Texas officials have asked a state court judge to temporarily block Kenvue Inc. from marketing Tylenol as safe for pregnant ...

Kenvue and Kimberly-Clark are merging in a $32B deal with $2.1B in synergies and major consumer health potential. Learn why KVUE and KMB are rated hold.

Kimberly-Clark is laying down $40 billion to buy Kenvue in a massive deal that has puzzled some investors as the Tylenol ...

By Jonathan Stempel (Reuters) -Texas Attorney General Ken Paxton asked a state judge on Thursday to block Kenvue from paying ...

Kimberly-Clark Corp. shares fell the most in a quarter century after agreeing to buy Kenvue Inc., whose biggest product, ...

The owner of Kleenex and Huggies will acquire the company that has fought unproven claims by the Trump administration that a ...

One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the common ...

Kimberly-Clark will acquire Kenvue, the Johnson & Johnson spinoff, in a $48.7B cash and stock deal to create a global consumer health leader.

Kleenex and Cottonelle maker Kimberly-Clark said it's buying Tylenol maker Kenvue in a $48.7 billion deal. Kenvue ( KVUE) ...

Aid maker Kenvue , even as the latter company faces thousands of lawsuits involving its painkiller Tylenol and talc-based ...

The news comes as Kenvue maker Tylenol has been embroiled in litigation surrounding the alleged relationship between Tylenol ...

2025 hasn't been kind to Kenvue ( KVUE +15.03%) stock lately. Shares of the one-time Johnson & Johnson unit got hit hard after President Donald Trump said it was "not good" for women to take Tylenol ...